We are live on ! Find out more
EDIT icon

Editas Medicine
EDIT

84 hedge funds and large institutions have $381M invested in Editas Medicine in 2016 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 23 increasing their positions, 18 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

290% more call options, than puts

Call options by funds: $335K | Put options by funds: $86K

100% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 10

64.09% more ownership

Funds ownership: 0% → 64.09% (+64%)

28% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 18

27% more capital invested

Capital invested by funds: $300M → $381M (+$81M)

12% more funds holding

Funds holding: 75 → 84 (+9)

20% less funds holding in top 10

Funds holding in top 10: 5 → 4 (-1)

Holders
84
Holders Change
+9
Holders Change %
+12%
% of All Funds
2.1%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.1%
New
20
Increased
23
Reduced
18
Closed
10
Calls
$335K
Puts
$86K
Net Calls
+$249K
Net Calls Change
+$325K

Top Buyers

1
EC
EcoR1 Capital
California
+$9.51M
2
BFA
BlackRock Fund Advisors
California
+$8.13M
3
FCMI
Foresite Capital Management III
California
+$4.17M
4
CS
Credit Suisse
Switzerland
+$2.14M
5
Norges Bank
Norges Bank
Norway
+$1.38M

Top Sellers

1
PVMCV
Polaris Venture Management Co VI
Massachusetts
-$5.45M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$3.69M
3
Renaissance Technologies
Renaissance Technologies
New York
-$1.73M
4
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
-$1.17M
5
Deutsche Bank
Deutsche Bank
Germany
-$847K
Name Holding Trade Value Shares
Change 		Change in
Stake
Wells Fargo
26
Wells Fargo
California
$806K +$718K +47,336 +2,073%
DCM
27
Driehaus Capital Management
Illinois
$756K +$707K +46,580 New
Bank of New York Mellon
28
Bank of New York Mellon
New York
$672K +$43.7K +2,878 +7%
WCM
29
Wildcat Capital Management
New York
$671K -$82.7K -5,451 -12%
Charles Schwab
30
Charles Schwab
California
$632K +$44.4K +2,926 +8%
HP
31
Harbourvest Partners
Massachusetts
$590K – – –
Susquehanna International Group
32
Susquehanna International Group
Pennsylvania
$563K +$527K +34,709 New
TD Asset Management
33
TD Asset Management
Ontario, Canada
$503K – – –
Swiss National Bank
34
Swiss National Bank
Switzerland
$489K +$307K +20,200 +204%
Goldman Sachs
35
Goldman Sachs
New York
$481K -$211K -13,917 -32%
BIM
36
BlackRock Investment Management
Delaware
$428K – – –
ARTA
37
A.R.T. Advisors
New York
$417K +$390K +25,700 New
ProShare Advisors
38
ProShare Advisors
Maryland
$411K +$384K +25,320 New
AllianceBernstein
39
AllianceBernstein
Tennessee
$393K – – –
Victory Capital Management
40
Victory Capital Management
Texas
$360K – – –
Bessemer Group
41
Bessemer Group
New Jersey
$354K – – –
TCIM
42
TIAA CREF Investment Management
New York
$336K -$6.83K -450 -2%
Squarepoint
43
Squarepoint
New York
$325K +$304K +20,026 New
SG Americas Securities
44
SG Americas Securities
New York
$319K +$298K +19,641 New
HLA
45
Hamilton Lane Advisors
Pennsylvania
$314K – – –
D.E. Shaw & Co
46
D.E. Shaw & Co
New York
$297K +$277K +18,277 New
Russell Investments Group
47
Russell Investments Group
United Kingdom
$284K +$268K +17,647 New
Group One Trading
48
Group One Trading
Illinois
$241K +$92.5K +6,097 +70%
California State Teachers Retirement System (CalSTRS)
49
California State Teachers Retirement System (CalSTRS)
California
$229K -$7.59K -500 -3%
BG
50
BlackRock Group
United Kingdom
$189K +$45.1K +2,973 +34%
1
2
3 4

EDIT Hedge Fund Activity: Q4 2016 in Review

84 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q4 2016, worth a combined $381M — up 27% from $300M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new EDIT positions and 10 closed out — a net gain of 10 holders — while 23 added to existing stakes and 18 trimmed.

The largest buyer was EcoR1 Capital, opening a new position worth an estimated $9.51M. The largest seller was Polaris Venture Management Co VI, cutting an estimated $5.45M.

  • 84 institutional investors held Editas Medicine (EDIT) as of Q4 2016, up from 75 in Q3 2016.
  • Funds reported $381M of Editas Medicine stock for Q4 2016, up 27% quarter-over-quarter.
  • 20 funds opened new Editas Medicine positions in Q4 2016 and 10 closed out, a net change of +10 holders.
  • The largest Editas Medicine buyer in Q4 2016 was EcoR1 Capital, an estimated $9.51M added.
  • The largest Editas Medicine seller in Q4 2016 was Polaris Venture Management Co VI, an estimated $5.45M sold.

Based on aggregated 13F filings for Q4 2016.